99 related articles for article (PubMed ID: 1566354)
1. Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia.
Bengtsson M; Simonsson B; Carlsson K; Nilsson B; Smedmyr B; Termander B; Oberg G; Tötterman TH
Transplantation; 1992 Apr; 53(4):882-8. PubMed ID: 1566354
[TBL] [Abstract][Full Text] [Related]
2. The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors.
Condiotti R; Slavin S; Barak V; Nagler A
Leuk Res; 1996 Jan; 20(1):57-63. PubMed ID: 8632678
[TBL] [Abstract][Full Text] [Related]
3. Natural effector cells in patients with acute myeloid leukemia treated with the immunomodulator Linomide after autologous bone marrow transplantation.
Hokland M; Jørgensen H; Holm MS; Simonsson B; Nilsson B; Bengtsson M; Hokland P
Eur J Haematol; 1999 Oct; 63(4):251-8. PubMed ID: 10530414
[TBL] [Abstract][Full Text] [Related]
4. Linomide administration following bone marrow transplantation in mice.
Weiss L; Abdul-Hai A; Shufaro Y; Reich S; Slavin S
Cancer Immunol Immunother; 2002 Dec; 51(11-12):596-602. PubMed ID: 12439604
[TBL] [Abstract][Full Text] [Related]
5. Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide.
Rowe JM; Nilsson BI; Simonsson B
Leuk Lymphoma; 1993 Nov; 11(5-6):321-9. PubMed ID: 7510190
[TBL] [Abstract][Full Text] [Related]
6. Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level.
Kalland T
J Immunol; 1990 Jun; 144(11):4472-6. PubMed ID: 2341727
[TBL] [Abstract][Full Text] [Related]
7. Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation.
Simonsson B; Tötterman T; Hokland P; Lauria F; Carella AM; Fernandez MN; Rozman C; Ferrant A; de Witte T; Zander AR; Meier K; Hansson F; Nilsson BI
Bone Marrow Transplant; 2000 Jun; 25(11):1121-7. PubMed ID: 10849523
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
9. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
Ericson SG; Colby E; Welch L; Ball ED
Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
[TBL] [Abstract][Full Text] [Related]
10. Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
Nagler A; Rabinowitz R; Rosengolts-Rat J; Condiotti R; Schlesinger M
J Hematother Stem Cell Res; 2000 Feb; 9(1):63-75. PubMed ID: 10738973
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.
Meloni G; Foà R; Tosti S; Vignetti M; Mancini F; Guarini A; Marchis D; Gavosto F; Mandelli F
Leukemia; 1992 Aug; 6(8):780-5. PubMed ID: 1640729
[TBL] [Abstract][Full Text] [Related]
12. Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis.
Tian WZ; Navikas V; Matusevicius D; Söderström M; Fredrikson S; Hedlund G; Link H
Acta Neurol Scand; 1998 Aug; 98(2):94-101. PubMed ID: 9724006
[TBL] [Abstract][Full Text] [Related]
13. Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice.
Xun C; Brown SA; Jennings CD; Henslee-Downey PJ; Thompson JS
Transplantation; 1993 Aug; 56(2):409-17. PubMed ID: 8356598
[TBL] [Abstract][Full Text] [Related]
14. The first clinical pilot study of roquinimex (Linomide) in cancer patients with special focus on immunological effects.
Bergh JC; Tötterman TH; Termander BC; Strandgarden KA; Gunnarsson PO; Nilsson BI
Cancer Invest; 1997; 15(3):204-11. PubMed ID: 9171853
[TBL] [Abstract][Full Text] [Related]
15. Autografting in chronic myelogenous leukemia followed by immunotherapy.
Rowe J; Ryan D; Dipersio J; Gaspari A; Nilsson B; Larsson L; Liesveld J; Kouides P; Simonsson B
Stem Cells; 1993 Oct; 11 Suppl 3():34-42. PubMed ID: 8298476
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Kalland T; Abramsky O
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6400-4. PubMed ID: 8341645
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells.
Lehmann D; Karussis D; Mizrachi-Koll R; Linde AS; Abramsky O
Clin Immunol Immunopathol; 1997 Nov; 85(2):202-9. PubMed ID: 9344704
[TBL] [Abstract][Full Text] [Related]
18. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
[TBL] [Abstract][Full Text] [Related]
19. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
20. Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
Lauria F; Raspadori D; Ventura MA; Rondelli D; Zinzani PL; Gherlinzoni F; Miggiano MC; Fiacchini M; Rosti G; Rizzi S; Tura S
Bone Marrow Transplant; 1996 Jul; 18(1):79-85. PubMed ID: 8831999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
